Anthony King is a science journalist whose work has been featured in various publications, including Chemistry World, Phys.org, Technology Networks, and Knowledia. With a focus on topics ranging from genetics and agriculture to medicine and technology, Anthony's articles provide in-depth coverage of scientific advancements and their impact on society.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Anthony King's articles primarily focus on scientific and healthcare topics, with an emphasis on expert commentary and industry-specific insights. His coverage encompasses a wide range of scientific developments, including medical research, health-related innovations, and government announcements in the field.
Given his extensive use of expert commentary and review content attributes, Anthony would likely be interested in receiving pitches from knowledgeable professionals within the scientific community who can provide unique perspectives or commentary on breakthroughs in medical research, health technologies, and pharmaceutical advancements.
If you have expertise related to Alzheimer's disease, medical research methodologies such as protein biomarkers or blood tests for neurodegenerative diseases like Alzheimer's Disease that align with Anthony’s coverage theme may increase your chances of successfully reaching out to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Anthony King
Highly selective mechanism can insert, remove and flip large portions of DNA
By: Anthony King
DoD should have consistent nutrition labeling and improve service members’ access to healthy foods at installations, according to a report from the Government Accountability Office.
This article explores how edible insects are being developed to address future food demands, focusing on safety, sustainability and the steps being taken to make these sources more acceptable to consumers.
Eli Lilly and Novo Nordisk invest to expand in-house manufacturing of GLP-1 drugs
By: Anthony King
Toxoplasma could be delivery agent for protein drugs - provided parasite can be made safe;
By: Anthony King
A parasite can ferry therapeutic proteins to brain cells, an international collaboration has demonstrated. A team at the University of Glasgow, UK, engineered the parasite, Toxoplasma gondii, so that it would deliver large proteins to human neurons (Nature Microbiology, DOI: 10.1038/s41564-024-01750-6 ).
Cobenfy promises to better address negative symptoms than existing antipsychotics
As legal challenges fall flat, will industry's claims of stifled innovation be borne out?
€15 billion deal sees Gulf oil producer looking to future growth beyond fuels
By: Anthony King
Counterintuitively, impact brought benefits too by providing microorganisms with iron and phosphorus
(833) 317-6278 
